Gabapentin for menopausal symptoms Menopause is a normal event, but some women have troublesome symptoms such as hot flushes and night sweats. The most effective treatment is menopausal hormone therapy (MHT). Gabapentin is a non-hormonal treatment that may be prescribed for women who need, or want, to avoid MHT. Gabapentin is used to treat vasomotor symptoms (VMS) in postmenopausal women with contraindications to hormonal therapy or who prefer alternatives. We investigated the efficacy and tolerability of gabapentin for treating menopausal hot flushes via a meta-analysis. Hot flashes (HFs), defined as transient sensations of heat, sweating, flushing, anxiety, and chills lasting for 1–5 min, constitute one of the most common symptoms of menopause among women though only a few seek treatment for these. The basis of HFs Gabapentin for Hot Flashes: Learn how this medication can help manage menopausal symptoms, including efficacy, dosage, and side effects. Several studies have shown that gabapentin (Neurontin) at 600-2400 mg/day in divided doses is effective for treating hot flashes in menopausal women. Research presented at the annual meeting of the North American Menopause Society (NAMS) indicates that an investigational extended release (ER) formulation of gabapentin (Serada, Depomed) is effective for the treatment of hot flashes and sleep Gabapentin is currently used for a variety of conditions/symptoms, such as epilepsy, pain after shingles (post herpetic neuralgia), insomnia, chronic pain restless leg syndrome, and anxiety. And of course, hot flashes. Abstract Objective: Gabapentin is used to treat vasomotor symptoms (VMS) in postmenopausal women with contraindications to hormonal therapy or who prefer alternatives. We investigated the efficacy and tolerability of gabapentin for treating menopausal hot flushes via a meta-analysis. Abstract Objective: To compare the effectiveness and tolerability of gabapentin with placebo for the treatment of hot flashes in women who enter menopause naturally. The North American Menopause Society and the American College of Obstetricians and Gynecologists recommend the use of gabapentin as an option for managing hot flashes in women who are unwilling to take estrogen-containing supplements. Gabapentin is usually used to control epilepsy or chronic nerve (neuropathic) pain. It is also a non-hormonal medicine that has been shown to be effective in reducing menopausal hot flushes. Gabapentin appears to be comparable with low dose oestrogen in reducing the frequency and severity of hot flushes.3 What is the usual dosage? Gabapentin and hot flashes Gabapentin is commonly used in neurology but rarely in gynecology. As it’s mainly used to prevent seizures, it’s difficult to see how it could help with hot flashes or night sweats. To understand how it could relieve your hot flashes, let’s look at what causes menopause. During menopause, your production of estrogen, progesterone, and testosterone reduces, and AMS Nonhormonal Treatments for Menopausal Symptoms 251.06 KB Many women seek non-hormonal treatments for menopausal symptoms. This information sheet addresses the evidence concerning safety and efficacy of currently available non-hormonal treatments for menopausal symptoms. These treatments are largely prescribed “off-label”. Off-label means use outside the specific purpose for which the The North American Menopause society and the American College of Obstetricians and Gynecologists recommend gabapentin as an option for managing hot flashes in women who are unwilling to take estrogen-containing supplements. Gabapentin’s role in improving vasomotor symptoms was shown in the BREEZE 1, 2, and 3 trials, 12–18 which looked at the efficacy of gabapentin ER (Serada®; Depomed, Inc, Newark, CA, USA), an investigational drug in treating menopausal hot flashes. Insomnia related to nighttime awakenings is known to be more prevalent in women than men. Three cases are presented here of late premenopausal women experiencing frequent nighttime awakenings that responded well to bedtime treatment with gabapentin. An investigational nonhormonal drug, extended-release gabapentin, effectively improved sleep and reduced hot flashes in menopausal women. This review investigated the efficacy and tolerability of gabapentin for the treatment of hot flashes in menopausal women. Gabapentin was associated with reductions in the severity and frequency of hot flashes in menopausal women, but there was substantial variation in the results across the included trials. The authors' conclusions appear to be reliable based on the evidence presented. Vasomotor symptoms are common among postmenopausal women and patients receiving hormone deprivation therapies, and emerging studies are exploring gabapentin’s and pregabalin’s effects as nonhormonal treatment options. We aimed to assess the efficacy and safety of these 2 drugs. Various non-hormonal agents have been used for the treatment of hot flashes in women with menopause. Some studies have reported that gabapentin appears to be an effective and well-tolerated treatment modality. The aim of this study was to evaluate
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |